Optonol

About

Funding history · 2 rounds · $30.0M total

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Optonol's primary product?

Optonol's flagship product is Ex-Press, a miniature surgical implant designed to lower intra-ocular pressure in glaucoma patients.

When was Optonol founded and what was its origin?

Optonol was founded in January 1996 as a spin-off from Medinol Ltd., a Jerusalem-based stent developer.

When and by whom was Optonol acquired?

Optonol was acquired by Alcon in December 2009 for $150,000,000.

What was the total amount of funding raised by Optonol before its acquisition?

Optonol raised a total of $30,000,000 in funding. For a full financing history, please refer to startupim.

Which investors participated in Optonol's Series A funding round?

In April 2006, Optonol secured Series A funding from investors including Israel HealthCare Ventures and Pitango VC.

What is the employee count for Optonol?

Optonol has an employee count of 1-10.

What is the status of Optonol as of December 2009?

Optonol's status changed to 'acquired' in December 2009, following its acquisition by Alcon.

Who are the listed founders of Optonol?

Yaron Ira and Benad Goldwasser are listed as founders of Optonol.

Sectors & technology

Highlights

Tags